The purpose of this guideline is to provide guidance on the care and use of long term Central Venous Access Devices (CVAD) including advice on dealing with any problems encountered. For the purpose of this guideline, devices that are required to remain insitu greater than a month will be considered a long term CVAD.
Note: While this guideline refers to the 'child' throughout, all activities are applicable to young people
This page from Great Ormond Street Hospital (GOSH) explains the neurological condition Vein of Galen Malformation (VGM). It aims to help understanding the condition, how it can be treated and what to expect when a child is admitted to GOSH.
Today Great Ormond Street Hospital Children’s Charity launches a new campaign which vividly chronicles the events during a day in the life of the hospital. One Day at GOSH is a compelling visual and intimate account of 24 hours at the hospital.
The charity’s film crew spent 24 hours in the company of patients, families, staff and volunteers of GOSH.
This information sheet explains the first phase of the assessment process to diagnose lower gastrointestinal dysmotility problems and what to expect when your child comes to Great Ormond Street Hospital (GOSH) for assessment.
The Department of Child and Adolescent Mental Health has an Intervention Service, coordinated by the Psychological Medicine Team, that offers brief, focused, evidence-based treatments to children with mental health difficulties.
The Child Accident Prevention Trust (CAPT) is calling on parents, grandparents, friends and family to ensure medicines and cleaning products are out of sight and reach of young children and to alert families to the risks of carbon monoxide poisoning this Christmas time.
Great Ormond Street Hospital (GOSH)’s mission is to provide world-class clinical care and training for the benefit of children in the UK and worldwide. This means that it is also our mission to pioneer new research and treatments for the children that we see at GOSH, particularly the very sick...
CLOSED: This scheme funds patient-focused early phase translational clinical research (commonly referred to as experimental medicine), the aim of which is to pull basic scientific discoveries into clinical research, and through to benefits for patients and the NHS. This can include development of new pharmaceuticals, devices, preventative measures and diagnostic tests.